Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins

od Lougheed, Julie C., Holton, James M., Alber, Tom, Bazan, J. Fernando, Handel, Tracy M.
Izdano 2001

Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial

od Escudier, Bernard, Powles, Thomas, Motzer, Robert J., Olencki, Thomas, Arén Frontera, Osvaldo, Oudard, Stephane, Rolland, Frederic, Tomczak, Piotr, Castellano, Daniel, Appleman, Leonard J., Drabkin, Harry, Vaena, Daniel, Milwee, Steven, Youkstetter, Jillian, Lougheed, Julie C., Bracarda, Sergio, Choueiri, Toni K.
Izdano u J Clin Oncol (2018)

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

od Kelley, Robin Kate, Ryoo, Baek-Yeol, Merle, Philippe, Park, Joong-Won, Bolondi, Luigi, Chan, Stephen L, Lim, Ho Yeong, Baron, Ari D, Parnis, Francis, Knox, Jennifer, Cattan, Stéphane, Yau, Thomas, Lougheed, Julie C, Milwee, Steven, El-Khoueiry, Anthony B, Cheng, Ann-Lii, Meyer, Tim, Abou-Alfa, Ghassan K
Izdano u ESMO Open (2020)

Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973)

od Rice, Kenneth D., Aay, Naing, Anand, Neel K., Blazey, Charles M., Bowles, Owen J., Bussenius, Joerg, Costanzo, Simona, Curtis, Jeffry K., Defina, Steven C., Dubenko, Larisa, Engst, Stefan, Joshi, Anagha A., Kennedy, Abigail R., Kim, Angie I., Koltun, Elena S., Lougheed, Julie C., Manalo, Jean-Claire L., Martini, Jean-Francois, Nuss, John M., Peto, Csaba J., Tsang, Tsze H., Yu, Peiwen, Johnston, Stuart
Izdano 2012